{"id":"W2121743767","doi":"10.1056/nejmoa1110557","title":"A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2050,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Ruxolitinib; Myelofibrosis; Janus kinase inhibitor; Placebo; Medicine; Janus kinase; Clinical trial; Janus kinase 2; Internal medicine; Double blind; Oncology; Pathology; Alternative medicine; Bone marrow; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002142657,0.001475323,0.00355486,0.0005157077,0.0005690956,0.0009080661,0.0008096949,0.00230879,0.008256052],"category_scores_gemma":[0.002759439,0.0006352012,0.001334714,0.0003189733,0.001168924,0.0008937995,0.0003893606,0.002171477,0.00129145],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004661353,"about_ca_system_score_gemma":0.0009358596,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003867718,"about_ca_topic_score_gemma":0.0006874986,"domain_scores_codex":[0.9989833,0.0005726638,0.00007746129,0.000195033,0.00006682059,0.0001047956],"domain_scores_gemma":[0.9988066,0.0003876782,0.0002966653,0.00009563974,0.00008454792,0.0003287872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9836347,0.00393538,0.0002022036,0.0006293736,0.000430832,0.00002453064,0.00002100491,0.0001072889,0.001671479,0.0000571085,0.0005196786,0.008766416],"study_design_scores_gemma":[0.9830856,0.01584567,0.0004639502,0.00001744092,0.0001058093,0.00001420305,0.000003893243,0.000117536,0.0001075197,0.00003568495,0.000197926,0.000004725903],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9742355,0.009757496,0.001267841,0.001258402,0.001558903,0.006981156,0.001362957,0.0003171329,0.003260697],"genre_scores_gemma":[0.981235,0.003002571,0.001872811,0.001593835,0.00085651,0.007604395,0.001023812,0.00002273675,0.002788544],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008256052,"threshold_uncertainty_score":0.02761924,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06223975921785737,"score_gpt":0.3486815480787401,"score_spread":0.2864417888608828,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}